ReCap™ Magnum™ by Biomet
The ReCap® Femoral Resurfacing System replaces the diseased surface of the femoral head and is designed to restore the normal anatomy and biomechanical function of the hip joint. The major advantage of the ReCap® Femoral Resurfacing System is its conservative nature. By avoiding medullary canal intrusion, it preserves valuable femoral bone stock, making it a bone-preserving alternative to total hip arthroplasty. A 2006 study published by Girard, J. et al. in the Journal of Bone and Joint Surgery (British) concluded that a group of young patients with femoral hemi-resurfacing were able to maintain a higher average activity level versus a similar group of patients who received a total hip arthroplasty1. Results suggest that improved resurfacing results may be attributed to the following:
Metal-on-metal articulations date back to the 1950s and offer a significant wear reduction compared with metal or ceramic-on-polyethylene while offering potentially higher stability and range of motion. The M2a-Magnum™ is an ultra-high performance metal-on-metal articulation offering superior joint mechanic restoration and full compatibility with Biomet’s clinically proven hip stems. Unlike ceramic-on-ceramic or traditional metal-on-polyethylene bearings, the M2a-Magnum™ Hip System offers the stability and ROM of a big ball (≥38mm) in acetabulums as small as 44mm.
ReCap® Total Hip Resurfacing System- Clinical Trial The Biomet® ReCap® Total Hip Resurfacing System clinical trial is approved by the Food and Drug Administration (FDA). The purpose of this research study is to determine the safety and effectiveness of a total resurfacing system utilizing a ReCap® Femoral Resurfacing Component and an M2a-Magnum™ Acetabular Shell. Click here for more information on the clinical trials for the ReCap® Total Hip Resurfacing System. ReCap® is a trademark of Biomet Manufacturing Corp. Information by Dr. GrossRecently, I have developed a fully porous coated femoral component with Biomet Inc. (Uncemented ReCap). This component is FDA approved in the US for femoral resurfacing. I have been using this together with the uncemented Magnum acetabular component for uncemented total Hip Surface Replacement since April 2007. No other surgeons are yet using this device. Dr. Gross South Carolina Joint Replacement Center |